Form 4: Corbus Pharmaceuticals Holdings Director Sells Shares
Insider Transaction (Form 4)
Yong Ben, a Director of Corbus Pharmaceuticals Holdings, Inc., sold 2,000 shares of common stock on September 14, 2026 for $7.84 per share.
Summary
- Open-market sale: disposed of 2,000 Common Stock, par value $0.0001 per share at $7.84 ($15,683) on September 14, 2026; holds 9,383 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $15,683 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Yong Ben — Director
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-14 | Open-market sale | Common Stock, par value $0.0001 per share | 2,000 | $8 | $15.7K | 9,383 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-14 | Open-market sale (2,000 shares) |
Keywords
insider transaction, Form 4, CRBP, Corbus Pharmaceuticals Holdings, Inc., bearish, Yong Ben
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.